Regulators To Take Close Look At Big Pharma Deals
One business day after generic drug giant Teva Pharmaceutical Industries Ltd. announced its plan to buy out rival Barr Pharmaceuticals Inc. for nearly $8 billion, Roche Holdings AG on Monday revealed...To view the full article, register now.
Already a subscriber? Click here to view full article